Ming Zhang

Dr. Ming Zhang

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Analytical Biochemistry
Verified
Journal Article
Closed access
MZMing Zhang
Ming Zhang
YXYan Xu
Yan Xu
LLLei Li
Lei Li
ZLZi Liu
Zi Liu
XYXibei Yang
Xibei Yang
Dong-Jun YuDong-Jun Yu
Dong-Jun Yu

1 September 2016 in Analytical Biochemistry
Verified
Journal Article
Closed access
MZMing Zhang
Ming Zhang
JSJia-Wei Sun
Jia-Wei Sun
ZLZi Liu
Zi Liu
MRMing-Wu Ren
Ming-Wu Ren
HSHong-Bin Shen
Hong-Bin Shen
Dong-Jun YuDong-Jun Yu
Dong-Jun Yu

11 November 2024 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
MZMing Zhang
Ming Zhang
JZJianren Zhou
Jianren Zhou
XWXiaohua Wang
Xiaohua Wang
XWXun Wang
Xun Wang
GFGe Fang
Ge Fang
Bioactive peptides are important bioactive molecules composed of short-chain amino acids that play various crucial roles in the body, such as regulating physiological processes and promoting immune responses and antibacterial effects. Due to their significance, bioactive peptides have broad application potential in drug development, food science, and biotechnology. Among them, understanding their biological mechanisms will contribute to new ideas for drug discovery and disease treatment. This study employs generative adversarial capsule networks (CapsuleGAN), gated recurrent units (GRU), and convolutional neural networks (CNN) as base classifiers to achieve ensemble learning through voting methods, which not only obtains high-precision prediction results on the angiotensin-converting enzyme (ACE) inhibitory peptides dataset and the anticancer peptides (ACP) dataset but also demonstrates effective model performance. For this method, we first utilized the protein language model—evolutionary scale modeling (ESM-2)—to extract relevant features for the ACE inhibitory peptides and ACP datasets. Following feature extraction, we trained three deep learning models—CapsuleGAN, GRU, and CNN—while continuously adjusting the model parameters throughout the training process. Finally, during the voting stage, different weights were assigned to the models based on their prediction accuracy, allowing full utilization of the model's performance. Experimental results show that on the ACE inhibitory peptide dataset, the balanced accuracy is 0.926, the Matthews correlation coefficient (MCC) is 0.831, and the area under the curve is 0.966; on the ACP dataset, the accuracy (ACC) is 0.779, and the MCC is 0.558. The experimental results on both datasets are superior to existing methods, demonstrating the effectiveness of the experimental approach. In this study, CapsuleGAN, GRU, and CNN were successfully employed as base classifiers to implement ensemble learning, which not only achieved good results in the prediction of two datasets but also surpassed existing methods. The ability to predict peptides with strong ACE inhibitory activity and ACPs more accurately and quickly is significant, and this work provides valuable insights for predicting other functional peptides. The source code and dataset for this experiment are publicly available at https://github.com/Zhou-Jianren/bioactive-peptides .

Verified
Journal Article
Open access
PDF file
GFGe Fang
Ge Fang
JZJianren Zhou
Jianren Zhou
MZMing Zhang
Ming Zhang
Dong-Jun YuDong-Jun Yu
Dong-Jun Yu
Bioactive peptides, composed of amino acid chains, are fundamental to a wide range of biological functions. Their inherent multifunctionality, however, complicates accurate classification and prediction. To address these challenges, we present MFP-MFL, an advanced multi-feature, multi-label learning framework that integrates Graph Attention Networks (GAT) with leading protein language models, including ESM-2, ProtT5, and RoBERTa. By employing an ensemble learning strategy, MFP-MFL effectively utilizes deep sequence features and complex functional dependencies, ensuring highly accurate and robust predictions of multifunctional peptides. Comparative experiments demonstrate that MFP-MFL achieves precision, coverage, and accuracy scores of 0.799, 0.821, and 0.786, respectively. Additionally, it attains an Absolute true of 0.737 while maintaining a low Absolute false of 0.086. A comprehensive case study involving 86,970 mutations further highlights the model’s ability to predict functional changes resulting from sequence variations. These results establish MFP-MFL as a powerful tool for the discovery and application of multifunctional peptides, offering significant potential to advance research and biomedical applications.

29 November 2024 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
XWXiaohua Wang
Xiaohua Wang
MZMing Zhang
Ming Zhang
XYXibei Yang
Xibei Yang
Dong-Jun YuDong-Jun Yu
Dong-Jun Yu
GFGe Fang
Ge Fang

Verified
Journal Article
Open access
PDF file
GFGe Fang
Ge Fang
CLCui-feng Li
Cui-feng Li
CZChao-Ming Zhang
Chao-Ming Zhang
MZMing Zhang
Ming Zhang
Dong-Jun YuDong-Jun Yu
Dong-Jun Yu
Protein–RNA interactions are essential to many cellular functions, and missense mutations in RNA-binding proteins can disrupt these interactions, often leading to disease. To address this, we developed PRITrans, a specialized computational method aimed at predicting the effects of missense mutations on protein–RNA interactions, which is vital for understanding disease mechanisms and advancing molecular biology research. PRITrans is a novel deep learning model designed to predict the effects of missense mutations on protein–RNA interactions, which employs a Transformer architecture enhanced with multiscale convolution modules for comprehensive feature extraction. Its primary innovation lies in integrating protein language model embeddings with a deep feature fusion strategy, effectively handling high-dimensional feature representations. By utilizing multi-layer self-attention mechanisms, PRITrans captures nuanced, high-level sequence information, while multiscale convolutions extract features across various depths, thereby enhancing predictive accuracy. Consequently, this architecture enables significant improvements in ΔΔG prediction compared to traditional approaches. We validated PRITrans using three different cross-validation strategies on two newly reconstructed mutation datasets, S315 and S630 (containing 315 forward and 315 reverse mutations). The results consistently demonstrated PRITrans’s strong performance on both datasets. PRITrans demonstrated strong predictive capability, achieving a Pearson correlation coefficient of 0.741 and a root mean square error (RMSE) of 1.168 kcal/mol on the S630 dataset. Moreover, its robust performance extended to independent test sets, achieving a Pearson correlation of 0.699 and an RMSE of 1.592 kcal/mol. These results underscore PRITrans’s potential as a powerful tool for protein-RNA interaction studies. Moreover, when tested against existing prediction methods on an independent dataset, PRITrans showed improved predictive accuracy and robustness.